Biosketch / Results /

Scott Sanderson

Clinical Assistant Professor, Department of Neurosurgery

Contact Info

203/792-2003
Scott.Sanderson@nyumc.org


A NON-INFERIORITY CLUSTER RANDOMISED TRIAL COMPARING TRADITIONAL FACE-TO-FACE AND DVD-BASED GENETIC COUNSELLING IN SYSTEMATIC POPULATION BASED BRCA1/2 TESTING
Manchanda, R; Loggenberg, K; Burnell, M; Wardle, J; Sanderson, S; Gessler, S; Side, L; Balogun, N; Desai, R; Kumar, A; Dorkins, H; Wallis, Y; Chapman, C; Tomlinson, I; Taylor, R; Jacobs, C; McGuire, A; Beller, U; Menon, U; Jacobs, I. A NON-INFERIORITY CLUSTER RANDOMISED TRIAL COMPARING TRADITIONAL FACE-TO-FACE AND DVD-BASED GENETIC COUNSELLING IN SYSTEMATIC POPULATION BASED BRCA1/2 TESTING [Meeting Abstract]. International journal of gynecological cancer. 2015 OCT;25(9):48-49 (2373112)

POPULATION-BASED TESTING FOR BRCA MUTATIONS (COMPARED TO FAMILY-HISTORY BASED TESTING) MAY BE COST SAVING IN ASHKENAZI-JEWS: A HEALTH-ECONOMICS DECISION ANALYTICAL MODEL
Manchanda, R; Legood, R; Burnell, M; McGuire, A; Loggenberg, K; Wardle, J; Sanderson, S; Gessler, S; Side, L; Balogun, N; Desai, R; Kumar, A; Dorkins, H; Wallis, Y; Chapman, C; Taylor, R; Jacobs, C; Beller, U; Menon, U; Jacobs, I. POPULATION-BASED TESTING FOR BRCA MUTATIONS (COMPARED TO FAMILY-HISTORY BASED TESTING) MAY BE COST SAVING IN ASHKENAZI-JEWS: A HEALTH-ECONOMICS DECISION ANALYTICAL MODEL [Meeting Abstract]. International journal of gynecological cancer. 2014 NOV;24(9):470-471 (2373062)

POPULATION PREVALENCE OF UK ASHKENAZI BRCA-MUTATIONS, PERFORMANCE OF AND ESTIMATED TIME-TO, FAMILY-HISTORY BASED IDENTIFICATION OF ALL BRCA CARRIERS.
Manchanda, R; Sanderson, S; Loggenberg, K; Burnell, M; Wardle, J; Gessler, S; Side, L; Balogun, N; Deshai, R; Kumar, A; Dorkins, H; Wallis, Y; Chapman, C; Taylor, R; Jacobs, C; Tomlinson, I; McGuire, A; Beller, U; Menon, U; Jacobs, IJ. POPULATION PREVALENCE OF UK ASHKENAZI BRCA-MUTATIONS, PERFORMANCE OF AND ESTIMATED TIME-TO, FAMILY-HISTORY BASED IDENTIFICATION OF ALL BRCA CARRIERS. [Meeting Abstract]. International journal of gynecological cancer. 2014 NOV;24(9):30-31 (2373052)

POPULATION BASED TESTING FOR BRCA MUTATIONS IS HIGHLY COST-EFFECTIVE COMPARED TO FAMILY HISTORY BASED APPROACH: A HEALTH-ECONOMIC DECISION ANALYTICAL MODEL FROM THE GCAPPS TRIAL
Manchanda, R; Legood, R; Burnell, M; McGuire, A; Legood, R; Loggenberg, K; Wardle, J; Sanderson, S; Gessler, S; Side, L; Desai, R; Kumar, A; Dorkins, H; Wallis, Y; Chapman, C; Jacobs, C; Tomlinson, I; Beller, U; Menon, U; Jacobs, I. POPULATION BASED TESTING FOR BRCA MUTATIONS IS HIGHLY COST-EFFECTIVE COMPARED TO FAMILY HISTORY BASED APPROACH: A HEALTH-ECONOMIC DECISION ANALYTICAL MODEL FROM THE GCAPPS TRIAL [Meeting Abstract]. International journal of gynecological cancer. 2013 OCT;23(8):?-? (2373002)

Population based testing for high-penetrance dominant gene mutations: initial results from the pilot phase of GCaPPS
Manchanda, R; Loggenberg, K; Gessler, S; Sanderson, S; Balogun, N; Wardle, J; Tomlinson, I; McGuire, A; Beller, U; Side, L; Menon, U; Jacobs, I. Population based testing for high-penetrance dominant gene mutations: initial results from the pilot phase of GCaPPS [Meeting Abstract]. International journal of gynecological cancer. 2012 MAY;22:S42-S43 (2372912)